The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Uterine cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations (BRCA+): A multicenter, prospective study.
 
Catherine A. Shu
No Relationships to Disclose
 
Malcolm C. Pike
No Relationships to Disclose
 
Anjali R. Jotwani
No Relationships to Disclose
 
Tara M. Friebel
No Relationships to Disclose
 
Robert A. Soslow
No Relationships to Disclose
 
Douglas A. Levine
No Relationships to Disclose
 
Mark E. Robson
Consulting or Advisory Role - AstraZeneca; Bayer; Biomarin; McKesson; Pfizer
Research Funding - AbbVie (Inst); AstraZeneca (Inst); Myriad Genetics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Biomarin
 
Jason A. Konner
No Relationships to Disclose
 
Joanne Lorraine Blum
No Relationships to Disclose
 
Susan L. Neuhausen
No Relationships to Disclose
 
Judy Ellen Garber
Consulting or Advisory Role - Novartis (I); pfizer; pfizer (I); Pfizer (I)
Research Funding - Myriad Genetics; Novartis; Novartis (I); Pfizer (I)
 
Mary Beryl Daly
No Relationships to Disclose
 
Claudine Isaacs
Honoraria - Celgene; Genentech/Roche
Speakers' Bureau - Celgene; Genentech
Research Funding - Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst)
 
Ros A. Eeles
No Relationships to Disclose
 
Patricia A. Ganz
Leadership - Intrinsic LifeSciences (I)
Stock and Other Ownership Interests - Intrinsic LifeSciences (I); Merganser Biotech (I); Silarus Therapeutics (I); xenon pharma (I)
Consulting or Advisory Role - Keryx (I); Merganser Biotech (I); Silarus Therapeutics (I)
Speakers' Bureau - Keryx (I)
Research Funding - Keryx (I)
Patents, Royalties, Other Intellectual Property - related to iron metabolism and the anemia of chronic disease (I)
Travel, Accommodations, Expenses - Intrinsic LifeSciences (I); Keryx (I)
 
Carol Aghajanian
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Abbvie; AstraZeneca
 
Kenneth Offit
No Relationships to Disclose
 
Susan M. Domchek
No Relationships to Disclose
 
Timothy R. Rebbeck
No Relationships to Disclose
 
Noah D. Kauff
No Relationships to Disclose